Publikationen

2013

75 Armacki M, Joodi G, Nimmagadda SC, de Kimpe L, PusapatiGV, Vandoninck S,  Van Lint J, Illing A and Seufferlein T.  A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growthby regulating angiogenesis,  Oncogene (2013), 1-14

74 Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, Jensen SG, Zöllner H, Maghnouj A, Wos A, Mayerle J, Munding J, Kost D, Reinacher-Schick A, Liffers S, Schroers R, Chromik AM, Meyer HE, Uhl W, Klein-Scory S, Weiss FU, Stephan C, Schwarte-Waldhoff I, Lerch MM, Tannapfel A, Schmiegel W, Andersen CL, Hahn SA.  Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.  Int J Cancer International Journal of Cancer 2013;132:E48-E57
 
73 Campa, D., Rizzato, C., Bauer, A.S., Werner, J., Capurso, G., Costello, E., Talar-Wojnarowska, R., Jamroziak, K., Pezzilli, R., Gazouli, M., Khaw, K.-T., Key, T.J., Bambi, F., Heller, A., Landi, L., Vodickova, L., Theodoropoulos, G., Bugert, P., Vodicka, P., Hoheisel, J.D., Neoptolemos, J.P., Soucek, P., Büchler, M.W., Giese, N. & Canzian, F.  Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol. Biomarkers Prev., in press

72 Fredebohm, J., Wolf, J., Hoheisel, J.D. & Böttcher, M. Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine.  J Cell Sci., in press.

71 Hoheisel, J.D., Alhamdani, M.S.S. & Schröder, C. Affinity-based microarrays for proteomic analysis of cancer tissues.  Proteomics Clin. Appl. 7, 8-16.
 
70 Lausser L, Müssel C, Maucher M, Kestler HA.  Measuring and visualizing the stability of biomarker selection techniques.  Computational Statistics. 2013; 28(1):51-65.

69 Munding JB, Adai AT, Maghnouj A, Urbanik A, Zollner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach A, Tannapfel A, Hahn SA.  Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.  Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19.

68 Schirwitz, C., Löffler, F., Felgenhauer, T., Stadler, V., Nesterov-Mueller, A., Dahint, R., Breitling, F. & Bischoff, F.R. Purification of high-complexity peptide microarrays by spatially resolved array transfer to gold-coated membranes.  Adv Materials 25, 1598-1602.

2012

67 Alhamdani, M.S.S., Youns, M., Buchholz, M., Gress, T.M., Beckers, M.C., Maréchal, D., Bauer, A.S., Schröder; C. & Hoheisel, J.D. Immunoassay-based proteome profiling of 24 pancreatic cancer cell lines.  J Proteomics 75, 3747-3759.

66 Ardito CM, Grüner BM, Takeuchi KK, Lubeseder-Martellato C, Teichmann N, Mazur PK, DelGiorno KE, Carpenter ES, Halbrook CJ, Hall JC, Pal D , Briel T, Herner A, Trajkovic-Arsic M, Sipos B, Liou GY, Storz P, Murray NR, Threadgill DW, Sibilia M, Washington MK, Wilson CL, Schmid RM, Raines EW, Crawford HC, Siveke JT.  EGF Receptor is Required for Kras-induced Pancreatic Tumorigenesis.  Cancer Cell 2012 Sep; 11;22(3):304-17. doi: 10.1016/j.ccr.2012.07.024.

65 Bauer AS, Keller, A., Costello-Goldring, E., Greenhalf, W., Bier, M., Borries, A., Beier, M., Neoptolemos, J.P., Büchler, M., Werner, J., Giese, N. & Hoheisel, J.D. Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microrna abundance in blood and tissue. PLoS ONE 7, e34151.

64 Botla, S.K., Gholami, A.M., Malekpour, M., Moskalev, E.A., Fallah, M., Jandaghi, P., Aghajani, A., Bondar, I.S., Omranipour, R., Malekpour, F., Mohajeri, A, Babadi, A.J., Sahin, Ö., Bubnov, V.V., Najmabadi, H., Hoheisel, J.D. & Riazalhosseini, Y.  Diagnostic values of GHSR DNA methylation pattern in breast cancer.  Breast Canc. Res. Treat. 135, 705-713. 

63 Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, Esposito I, Friess H, Gress TM, Habisch HJ, Hwang RF, Jaster R, Kleeff J, Klöppel G, Kordes C, Logsdon CD, Masamune A, Michalski CW, Oh J, Phillips PA, Pinzani M, Reiser-Erkan C, Tsukamoto H, Wilson J.  StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012 Feb;61(2):172-8. doi: 10.1136/gutjnl-2011-301220. Epub 2011 Nov 24.

62 Erkan M, Reiser-Erkan C, Michalski CW, Kong B, Esposito I, Friess H, Kleeff J. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. Curr Mol Med. 2012;12(3):288-303.

61 Fredebohm J, Boettcher M, Eisen C, Gaida MM, Heller A, Keleg S, Tost J, Greulich-Bode KM, Hotz-Wagenblatt A, Lathrop M, Giese NA, Hoheisel JD.   Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.   PLoS One 2012; 7:e48503.

60 Gress TM, Kestler HA, Lausser L, Fiedler L, Sipos B, Michalski CW, Werner J, Giese N, Scarpa A, and Buchholz M.  Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens.  J Mol Med., 90: 457-464.

59 Grüner BM, Hahne H, Mazur PK, Trajkovic-Arsic M, Maier S, Esposito I, Kalideris E, Michalski CW, Kleeff J, Rauser S, Schmid RM, Küster B, Walch A, Siveke JT.  MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.  PLoS ONE 2012; 7(6):e39424. doi: 10.1371/journal.pone.0039424.

58 Hoheisel, J.D. Antikörper zur Funktions-Analyse des Proteoms. Laborwelt 3, 16-17.

57 Lausser L, Müssel C, Melkozerov A, Kestler HA.  Identifying predictive hubs to condense the training set of k-nearest neighbour classifiers.  Computational Statistics. 2012.

56 Moskalev, E.A., Luckert, K., Vorobjev, I.A., Mastitsky, S.E., Gladkikh, A.A., Stephan, A., Schrenk, M. Pötz, O., Joos, T.O. & Hoheisel, J.D.  Concurrent epigenetic silencing of Wnt/?-catenin pathway inhibitor genes in B-cell chronic lymphocytic leukemia.  BMC Cancer 12, 213.

55 Moskalev, E.A., Schubert, M. & Hoheisel, J.D. RNA-directed epigenomic reprogramming ? an emerging principle of a more targeted cancer therapy? Genes Chrom.  Cancer 51, 105-110.

54 Müssel C, Lausser L, Maucher M, Kestler HA.  Multi-Objective parameter selection for classifiers.  Journal of Statistical Software. 2012; 46(5):1?27.

53 Pusapati GV, Eiseler T, Rykx A, Vandoninck S, Derua R, Waelkens E, Van Lint J, von Wichert G, Seufferlein T.  Protein Kinase D Regulates RhoA Activity via Rhotekin Phosphorylation.  J Biol Chem. 2012 Mar 16;287(12):9473-83. Epub 2012 Jan 6

52 Rachakonda, P.S., Bauer, A.S., Xie, H., Campa, D., Rizzato, C., Canzian, F., Beghelli, S., Greenhalf, W., Costello, E., Schanne, M. Heller, A., Scarpa, A., Neoptolemos, J.P., Werner, J., Büchler, M., Hoheisel, J.D., Hemminki, K., Giese, N. & Kumar, R. Somatic mutations in exocrine pancreatic tumors: association with patient survival.  PLoS ONE 8, e60870.

51 Rizzato, C., Campa, D., Giese, N., Werner, J., Rachakonda, S.P., Kumar, R., Schanné, M., Greenhalf, W., Costello, E., Khaw, K.T., Key, T.J., Siddiq, A., Lorenzo-Bermejo, J., Burwinkel, B., Neoptolemos, J.P., Büchler, M.W., Hoheisel, J.D., Bauer, A. & Canzian, F.  Pancreatic cancer susceptibility loci and their role in survival.  PLoS ONE 6, e27921.

50 Rizzato, C., Campa, D., Pezzilli, R., Soucek, P., Greenhalf, W., Capurso, G., Talar-Wojnarowska, R., Heller, A., Jamroziak, K., Khaw, K.-T., Key, T.J., Bambi, F., Landi, S., Vodickova, L., Büchler, M.W., Bugert, P., Vodicka, P., Neoptolemos, J.P., Werner, J., Hoheisel, J.D., Bauer, A.S., Giese, N. & Canzian, F. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.  Oncol. Report 29, 1637-1644.                                                                                                    

49 Schirwitz, C., Löffler, F., Felgenhauer, T., Stadler, V., Breitling, F. & Bischoff, F.R.  Sensing immune responses with customized peptide microarrays.  Biointerphases 7, 47.

48 Siveke JT, Crawford HC.  Kras above and beyond - EGFR in pancreatic cancer.  Oncotarget 2012; Nov;3(11):1262-3.

47 Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M,Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B.  Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.  Int J Cancer. 2012, 131:E371-381

2011

46 Adamczyk KA, Klein-Scory S, Tehrani MM, Warnken U, Schmiegel W, Schnölzer M, Schwarte-Waldhoff I. Characterization of soluble and exosomal forms of the EGFR released from pancreatic cancer cells. Life Sci. 2011 Aug 29;89(9-10):304-12. Epub 2011 Jul 6

45 Buchholz M, und Gress TM. Molekulare Pathogenese zystischer Neoplasien im Pankreas. Viszeralmedizin 27:189?193.

44 Erkan M, Reiser-Erkan C, Michalski CW, Kong B, Esposito I, Friess H, Kleeff J. The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance. Curr Mol Med. 2012;12(3):288-303.Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, Esposito I, Friess H, Gress TM, Habisch HJ, Hwang RF, Jaster R, Kleeff J, Klöppel G, Kordes C, Logsdon CD, Masamune A, Michalski CW, Oh J, Phillips PA, Pinzani M, Reiser-Erkan C, Tsukamoto H, Wilson J. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61(2):172-8.

43 Gress TM, Kestler HA, Lausser L, Fiedler L, Sipos B, Michalski CW, Werner J, Giese N, Scarpa A, Buchholz M. Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens. J Mol Med (Berl). 2012 Apr;90(4):457-64. Epub 2011 Nov 26.

42 Hann A, Gruner A, Chen Y, Gress TM, and Buchholz M. Comprehensive analysis of cellular galectin-3 reveals no consistent oncogenic function in pancreatic cancer cells. PLoS One. 2011;6(6):e20859. Epub 2011 Jun 16.

41 Heid I, Lubeseder-Martellato C, Sipos B, Mazur PK, Lesina M, Schmid RM, Siveke JT. Early requirement of Rac1 in a mouse model of pancreatic cancer. Gastroenterology. 2011;141:719-30.

40 Holtrup, F., Bauer, A., Fellenberg, K., Hilger, R.A., Wink, M. & Hoheisel, J.D. Nemorosone specifically inhibits growth of pancreatic cancer cells and induces apoptosis via activation of the unfolded protein response (UPR). Brit. J. Pharmacol. 162, 1045-1059 (2011).

39 Huth J, Buchholz M, Kraus JM, Molhave K, Gradinaru C, v. Wichert G, Gress TM, Neumann H, Kestler HA. TimeLapseAnalyzer: multi-target analysis for live-cell imaging and time-lapse microscopy. Comput Methods Programs Biomed. 2011 Nov;104(2):227-34. Epub 2011 Jun 25.

38 Keller, A., Leidinger, P., Bauer, A., ElSharawi, A., Haas, J., Backes, C., Wendschlag, A., Giese, N., Tjaden, C., Ott, K., Werner, J., Hackert, T., Ruprecht, K., Huwer, H., Huebers, J., Jacobs, G., Rosenstiel, P., Dommisch, H., Schäfer, A., Müller-Quernheim, J., Wullich, B., Keck, B., Graf, N., Reichrath, J., Vogel, B., Nebel, A., Jager, S.U., Staehler, P., Amarantos, I., Boisguerin, V., Staehler, C., Beier, M., Scheffler, M., Büchler, M.W., Wischhusen, J., Häusler, S.F.M., Dietl, J., Hofmann, S., Lenhof, H.P., Schreiber, S., Katus, H.A., Rottbauer, W., Meder, B., Hoheisel, J.D., Franke, A. & Meese, E. Toward the blood-borne miRNome of human diseases. Nature Methods. 2011 Sep 4;8(10):841-3. doi: 10.1038/nmeth.1682.

37 Kestler HA, Lausser L, Lindner W, Palm G. On the fusion of threshold classifiers for categorization and dimensionality reduction. Computational Statistics. 2011; 26(2): 321 - 340.

36 Kraus JM, Müssel C, Palm G, Kestler HA. Multi-objective selection for collecting cluster alternatives. Computational Statistics. 2011; 26(2): 341- 354.

35 Maucher M, Kracher B, Kühl M, Kestler HA. Inferring Boolean network structure via correlation. Bioinformatics. 2011; 27(11): 1529-36.

34 Maucher M, Schöning U, Kestler HA. Search heuristics and the influence of non-perfect randomness: examining Genetic Algorithms and Simulated Annealing. Computational Statistics. 2011; 26(2): 303 - 320.

33 Mazur PK, Siveke JT. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology. Gut. 2011 Aug 26. [Epub ahead of print]

32 Meyer LH, Eckhoff SM, Queudeville M, Kraus JM, Giordan M, Stursberg J, Zangrando A, Vendramini E, Möricke A, Zimmermann M, Schrauder A, Lahr G, Holzmann K, Schrappe M, Basso G, Stahnke K, Kestler HA, Te Kronnie G., Debatin KM. Early relapse in all is identified by time to leukemia in NOD/SCID mice and is characterized by a gene signature involving survival pathways. Cancer Cell. 2011; 19(2): 206-17.

31 Moskalev, E.A., Schubert, M. & Hoheisel, J.D. RNA-directed epigenomic reprogramming ? an emerging principle of a more targeted cancer therapy? Genes Chrom. Cancer 51, 105-110 (2012).

30 Moskalev, E.A., Zavgorodnij, M.G., Majorova, S.P., Vorobjev, I.A., Jandaghi, P., Bure, I.V. & Hoheisel, J.D. Correction of PCR-bias in quantitative DNA methylation studies by means of cubic polynomial regression. Nucleic Acids Res. 2011 Jun;39(11):e77. Epub 2011 Apr 12.

29 Munding JB, Adai AT, Maghnouj A, Urbanik A, Zollner H, Liffers ST, Chromik AM, Uhl W, Szafranska-Schwarzbach A, Tannapfel A, Hahn SA. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer. 2012 Jul 15;131(2):E86-95. doi: 10.1002/ijc.26466. Epub 2011 Nov 19.

28 Mustafa, S.A., Hoheisel, J.D. & Alhamdani, M.S.S. Secretome profiling with antibody microarrays. Mol. Biosyst. 7, 1795-1801 (2011).

27 Raszeja L, Maghnouj A, Hahn S, Metzler-Nolte N. A. Novel Organometallic ReI Complex with Favourable Properties for Bioimaging and Applicability in Solid-Phase Peptide Synthesis. ChemBioChem 2011;12:371-6.

26 Rizzato, C., Campa, D., Giese, N., Werner, J., Rachakonda, S.P., Kumar, R., Schanné, M., Greenhalf, W., Costello, E., Khaw, K.T., Key, T.J., Siddiq, A., Lorenzo-Bermejo, J., Burwinkel, B., Neoptolemos, J.P., Büchler, M.W., Hoheisel, J.D., Bauer, A. & Canzian, F. Pancreatic cancer susceptibility loci and their role in survival. PLoS ONE 6, e27921 (2011).

25 Schmidt, R., Jacak, J., Schirwitz, C., Stadler, V., Michel, G., Marmé, N., Schütz, G.J., Hoheisel, J.D. & Knemeyer, J.-P. Single-molecule detection on a protein-array assay platform for the exposure of a tuberculosis antigen. J Proteome Res. 10, 1316-1322 (2011).

24 Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M,Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B. Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductaladenocarcinoma. Int J Cancer. 2011 Oct 23. doi: 10.1002/ijc.26502. [Epub ahead ofprint] PubMed PMID: 22020953.

23 Torres Salazar, A., Hoheisel, J.D., Youns, M. & Wink, M. Anti-inflammatory and anti-cancer activities of essential oils and their biological constituents. Int. J. Clin. Pharmacol. Ther. 49, 93-95 (2011).

22 Welsch T, Zschäbitz S, Becker V, Giese T, Bergmann F, Hinz U, Keleg S, Heller A, Sipos B, Klingmüller U, Büchler MW, Werner J, Giese NA. Prognostic significance of erythropoietin in pancreatic adenocarcinoma. PLoS One. 2011;6(8):e23151. Epub 2011 Aug 1.

21 Youns, M., Bauer, A., Reichling, J., Fellenberg, K., Efferth, T. & Hoheisel, J.D. Gene expression profiling identifies novel key players involved in chemopreventive effect of NS-398 on pancreatic cancer cells. Eur. J. Pharmacol. 650, 170-177 (2011).

2010

20 Alhamdani, M.S., Schröder, C. & Hoheisel, J.D. Analysis conditions for proteomic profiling of mammalian tissue and cell extracts with antibody microarrays. Proteomics 10, 3203-3207.

19 Alhamdani, M.S.S., Schröder, C., Giese, N., Bauer, A. & Hoheisel, J.D. Single-step procedure for the isolation of proteins at near-native conditions from mammalian tissue for proteomic analysis on antibody microarrays. J. Prot. Res. 9, 963-971.

18 Azoitei N, Pusapati GV, Kleger A, Möller P, Küfer R, Genze F, Wagner M, van Lint J, Carmeliet P, Adler G, Seufferlein T. Protein kinase D2 is a crucial regulator of tumor cell-endothelial cell communication in gastrointestinal tumors. GUT. 2010; Oct;59(10):1316-30. Epub 2010 Aug 23.

17 Erkan M, Weis N, Pan Z, Schwager C, Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J, Huber PE, Friess H, Abdollahi A, and Kleeff J. Organ-, Inflammation- and Cancer Specific Transcriptional Fingerprints of Pancreatic and Hepatic Stellate Cells. Mol Cancer 2010, 9:88.

16 Gloriam, D.E., Orchard, S., Bertinetti, D., Bjorling, E., Bongcam-Rudloff, E., Bourbeillon, J., Bradbury, A.R., de Daruvar, A., Dübel, S., Frank, R., Gibson, T.J., Haslam, N., Herberg, F.W., Hiltke, T., Hoheisel, J.D., Kerrien, S., Koegl, M., Konthur, Z., Korn, B., Landegren, U., van der Maarel, S., Montecchi-Palazzi, L., Palcy, S., Rodriguez, H., Schweinsberg, S., Sievert, V., Stoevesandt, O., Taussig, M.J., Uhlen, M., Wingren, C., Gold, L., Woollard, P., Sherman, D.J. & Hermjakob, H. A community standard for the representation of protein affinity reagents. Mol. Cell. Prot. 9, 1-10.

15 Heller A, Zörnig I, Müller T, Giorgadze K, Frei C, Giese T, Bergmann F, Schmidt J, Werner J, Buchler MW, Jaeger D, Giese NA. Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer. Cancer Immunol Immunother. 2010 Sep;59(9):1389-400. Epub 2010 Jun 1.

14 Huth J, Buchholz M, Kraus JM, Schmucker M, von Wichert G, Krndija D, Seufferlein T, Gress TM, Kestler HA. Significantly improved precision of cell migration analysis in time-lapse video microscopy through use of a fully automated tracking system. BMC Cell Biol, 11:24, 2010.

13 Kraus JM, Kestler HA. A highly effcient multi-core algorithm for clustering extremely large datasets. BMC Bioinformatics, 11(1):169, 2010.

12 Maucher M, Schöning U, Kestler HA. Search heuristics and the influence of non-perfect randomness. Comput Stat. 2010;  in press.

11 Mazur PK, Einwächter H, Lee M, Sipos B, Nakhai H, Rad R, Zimber-Strobl U, Strobl LJ, Radtke F, Klöppel G, Schmid RM,  Siveke JT. Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma. PNAS. 2010;107(30):13438-43.

10 Müssel C, Hopfensitz M, Kestler HA. BoolNet - an R package for generation, reconstruction, and analysis of Boolean networks. Bioinformatics, 26(10):1378?1380, 2010.

9 Pinto, L., Efferth, T., Torres, A., Hoheisel, J.D. & Youns, M. Berberine selectively inhibits cell growth and mediates caspase-independent cell death in human pancreatic cancer cells. Planta Med. 76, 1155-1161.

8 Schröder, C., Jacob, A., Tonack, S., Radon, T., Sill, M., Zucknick, M., Rüffer, S., Costello, E., Neoptolemos, J., Crnogorac-Jurcevic, T., Bauer, A., Fellenberg, K. & Hoheisel, J.D. Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-specific antibodies. Mol. Cell. Prot. 9, 1271-1280.

7 Sill, M., Schröder, C., Hoheisel, J.D., Benner, A. & Zucknick, M. Assessment and optimisation of normalisation methods for dual-colour antibody microarrays. BMC Bioinformatics 11, 556.

6 Song Z, von Figura G, Liu Y, Kraus JM, Torrice C, Dillon P, Rudolph-Watabe M, Ju Z, Kestler HA, Sanoff H, Rudolph KL. Lifestyle impacts on the aging-associated expression of biomarkers of DNA damage and telomere dysfunction in human blood. Aging Cell. 607-15, Epub 2010 Jun 17.

2009

5 Bauer, A., Kleeff, J., Bier, M., Wirtz, M., Kayed, H., Esposito, I., Korc, M., Hafner, M., Hoheisel, J.D. & Friess, H. (2009). Identification of malignancy factors by analysing cystic tumours of the pancreas. Pancreatology 9, 34-44.

4 Ketterer, K., Kong, B., Frank, D., Giese, N., Bauer, A., Hoheisel, J.D., Korc, M., Kleeff, J., Michalski, C. & Friess, H. (2009). Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. Cancer Lett. 277, 72-81.

3 Sipos B, Frank S, Gress T, Hahn S, Klöppel G. Pancreatic intraepithelial neoplasia revisited and updated. Pancreatology. 2009;9(1-2):45-54.

2 Youns, M., Efferth, T., Reichling, J., Fellenberg, K., Bauer, A. & Hoheisel, J.D. (2009). Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells. Biochem. Pharmacol. 2009; 78, 273-283.

2008

1 Buchholz M, Kestler H, Gress TM. Differential diagnosis of pancreatic tumors by molecular analysis of clinical specimens. Pancreatology. 2008;8(6):551-7.